Login / Signup

Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation.

Siok-Keen TeySteven W Lane
Published in: Blood advances (2021)
Keyphrases
  • stem cell transplantation
  • high dose
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • low dose
  • bone marrow